Search results for "Cirrhosis"
Spotlight on direct-acting antivirals
Studies of contemporary populations with hepatitis C virus infection demonstrated that treatment with direct-acting antiviral therapies was linked to improvement in several long-term clinical outcomes.
https://gastroenterology.acponline.org/archives/2019/02/22/5.htm
22 Feb 2019
MKSAP quiz: HCV-related cirrhosis with decompensation
This month's quiz asks readers to determine the next step in management for a 64-year-old man with hepatitis C virus (HCV)-related decompensation.
https://gastroenterology.acponline.org/archives/2019/03/22/4.htm
22 Mar 2019
Daily aspirin may reduce risk of hepatitis-related liver cancer
A Taiwanese nationwide cohort study of more than 10,000 patients with chronic hepatitis B showed a statistically significant 29% risk reduction for hepatocellular carcinoma in patients who received daily aspirin compared with matched controls.
https://gastroenterology.acponline.org/archives/2019/03/22/1.htm
22 Mar 2019
Beta-blockers linked to better outcomes in some patients with cirrhosis
Decompensation-free survival improved in patients with cirrhosis and portal hypertension who received beta-blockers versus placebo, largely due to a decrease in ascites.
https://gastroenterology.acponline.org/archives/2019/04/26/3.htm
26 Apr 2019
MKSAP quiz: HBV in pregnancy
This month's quiz asks readers to determine the next appropriate step in management for a 28-year-old woman with hepatitis B virus (HBV) who is 28 weeks pregnant.
https://gastroenterology.acponline.org/archives/2019/05/24/4.htm
24 May 2019
Weight loss interventions may improve biomarkers of liver disease in NAFLD
In a meta-analysis of 22 studies in patients with nonalcoholic fatty liver disease (NAFLD), weight loss interventions were associated with improvements in alanine aminotransferase level, liver steatosis, histologic NAFLD activity score, and nonalcoholic steatohepatitis.
https://gastroenterology.acponline.org/archives/2019/07/26/3.htm
26 Jul 2019
Spotlight on new guidelines
The American Association for the Study of Liver Diseases, the American Gastroenterological Association, the American College of Gastroenterology, and the U.S. Preventive Services Task Force all released new guidelines this month.
https://gastroenterology.acponline.org/archives/2019/07/26/5.htm
26 Jul 2019
Study identifies potential predictors of hospital-onset C. difficile infection
In patients colonized with Clostridioides difficile, risk factors for infection included longer length of stay, exposure to multiple classes of antibiotics, use of opioids, and cirrhosis, whereas use of laxatives was associated with a lower risk.
https://gastroenterology.acponline.org/archives/2019/07/26/8.htm
26 Jul 2019
In compensated cirrhosis with portal hypertension, beta-blockers reduced a composite of decompensation or death
The trial results cannot be generalized to all patients with cirrhosis, and future trials should look at whether similar effects could be achieved simply by limiting salt intake, an ACP Journal Club commentary said.
https://gastroenterology.acponline.org/archives/2019/08/23/10.htm
23 Aug 2019
Spotlight on HCV guidance
Recommendations from the U.S. Preventive Services Task Force, the Kidney Disease: Improving Global Outcomes (KDIGO) work group, and the Choosing Wisely campaign all focused on hepatitis C virus (HCV) infection.
https://gastroenterology.acponline.org/archives/2019/09/27/5.htm
27 Sep 2019